Company Close Updates

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors

Company Logo

Terrence Horan

Referenced Symbols

Shares of TherapeuticsMD Inc. TXMD, +0.56% slid 0.52% to $0.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, -0.03% rising 0.82% to 15,161.53 and the Dow Jones Industrial Average DJIA, +0.10% rising 0.68% to 34,814.39. This was the stock's second consecutive day of losses. TherapeuticsMD Inc. closed $2.03 short of its 52-week high ($2.75), which the company achieved on February 9th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -0.30% rose 0.38% to $165.42, Merck & Co. Inc. MRK, +0.77% rose 0.97% to $72.81, and Novartis AG ADR NVS, -0.77% fell 0.23% to $85.08. Trading volume (6.3 M) eclipsed its 50-day average volume of 5.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.